000 | 00968 a2200253 4500 | ||
---|---|---|---|
005 | 20250517212800.0 | ||
264 | 0 | _c20190802 | |
008 | 201908s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mdy122 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEfstathiou, E | |
245 | 0 | 0 |
_aThe case for 'successfully' treating hormone naïve metastatic prostate cancer. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c05 2018 |
||
300 |
_a1084-1086 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAndrostenes |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aProstatic Neoplasms |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 29 _gno. 5 _gp. 1084-1086 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdy122 _zAvailable from publisher's website |
999 |
_c28319619 _d28319619 |